This inventor holds 4 USPTO granted patents. Top assignee: Pfizer Corporation. Active years: 1988-1989.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1988-1989
Title: David L. Lindner: Innovator in Antibiotic Development
Introduction
David L. Lindner is a prominent inventor based in Niantic, CT (US). He has made significant contributions to the field of antibiotic development, holding a total of 4 patents. His work focuses on innovative processes for creating effective antibacterial agents.
Latest Patents
Lindner's latest patents include a process for 2-(1-oxo-3-thiolanyl)-2-penem antibiotics. This involves the conversion of 3R,4R-4-acetoxy-3-[1R-1-(silyloxy)ethyl]-2-acetidinones to antibacterial 5R,6S-6-(1R-1-hydroxyethyl)-2-(1-oxo-3-thiolanylthio)-2-penem-3-carboxylic acids, along with their pharmaceutically-acceptable salts and pivaloyloxymethyl esters. Another notable patent is for a similar process involving 3R,4R-4-acetoxy-3-[1R-1-(silyloxy)ethyl]-2-azetidinones, leading to the same antibacterial compounds.
Career Highlights
David L. Lindner is currently associated with Pfizer Corporation, a leading pharmaceutical company. His work at Pfizer has been instrumental in advancing antibiotic research and development.
Collaborations
Lindner has collaborated with notable colleagues, including Robert A. Volkmann and Katherine E. Brighty. These partnerships have contributed to the success of his innovative projects.
Conclusion
David L. Lindner's contributions to antibiotic development through his patents and collaborations highlight his role as a key innovator in the pharmaceutical industry. His work continues to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile